Clinical investigation in duchenne muscular dystrophy: IV. Double. Blind controlled trial of leucine

Muscle & Nerve

Volumn 7, Issue 7, 1984, Pages 535-541

  Mendell, Jerry R ^a   Griggs, Robert C ^b   Moxley, Richard T ^b   Fenichel, Gerald M ^d   Brooke, Michael H ^c,e   Miller, J Philip ^c,e   Province, Michael A ^c,e   Dodson, W Edwin ^c,e  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b STRONG MEMORIAL HOSPITAL   (United States)

^c Department of Neurology and Neurosurgery ^*  (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE; PLACEBO; RADIOISOTOPE;

CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG THERAPY; DUCHENNE MUSCULAR DYSTROPHY; HUMAN; JOINT; JOINT CONTRACTURE; LEUCINE C 13; MUSCLE; THERAPY;

CHILD; CLINICAL TRIALS; CONTRACTURE; DOUBLE-BLIND METHOD; ENZYMES; HUMAN; LEUCINE; MUSCLES; MUSCULAR DYSTROPHIES; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0021130551     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.880070704     Document Type: Article

References (18)

1. Duchenne dystrophy: focal alterations in the distribution of concanavalin A binding sites at the muscle cell surface
2. Clinical investigation in Duchenne dystrophy: II. Determination of the “power” of therapeutic trials based on the natural history
3. Clinical trial in Duchenne dystrophy. I. The design of the protocol
4. Leucine: a possible regulator of protein turn‐over in muscle
5. Use of a natural history phase for the design of trials for Duchenne muscular dystrophy
6. Clinical trials in Duchenne muscular dystrophy: III. Standardization and reliability of evaluation procedures
7. Effect of insulin, glucose and amino acids on protein turn‐over in rat diaphragm
8. Regulation and significance of amino acid metabolism in skeletal muscle
9. The use of an extended baseline period in the evaluation of the longitudinal data of a clinical trial
10. 13] leucine
11. Adenyl cyclase abnormality in Duchenne muscular dystrophy: muscle cell in culture
12. T methylhistidine in urine
13. Duchenne dystrophy: electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber
14. Duchenne dystrophy: alteration in muscle plasma membrane structure
15. Branched‐chain keto acids reduce muscle protein degradation in Duchenne muscular dystrophy